Indianapolis-based Gate Neurosciences to acquire California-based startup
Indianapolis-based Gate Neurosciences, which is in clinical trials of a medicine to treat depression, plans to acquire California-based biotech startup Boost Neuroscience.
Bioscience
-
Life sciences industry booster BioCrossroads girds for new challenges
Patricia Martin, the group’s president and CEO since 2019, last month announced she would step down to examine opportunities in the private sector and urged industry leaders to take a fresh look at the organization.
Read More -
Inotiv plans to close two Indianapolis facilities in consolidation
The pharmaceutical testing company said it plans to close two isolator facilities in Indianapolis and consolidate them with existing facilities in the United States.
Read More -
Corteva buys Houston-based plant biologics company for $1.2B
The acquisition is designed to accelerate Indianapolis-based Corteva’s biologicals business and make it one of the largest players in the market.
Read More -
Noblesville leaders expand scope of planned Innovation Mile
City leaders expect a stretch of undeveloped agricultural land on the city’s southeast side to become Hamilton County’s next epicenter of innovation.
Read More
Articles
Commerce chief David Rosenberg to lead IU biosciences accelerator in Indy
Known as IU LAB and supported by a $138 million grant from the Lilly Endowment, the IU Launch Accelerator for Biosciences will be based at the 16 Tech Innovation District.
UPDATE: IU lands $138M grant from Lilly Endowment to fund new biosciences accelerator
The gift is the largest grant that Indiana University has ever received in support of research and development. IU President Pamela Whitten said the funding will help “change the very landscape of our capital city and state.”
Corteva takes $25M stake in North Carolina gene-editing agriculture company
Corteva, the Indianapolis-based seed and crop protection giant, formed a joint venture with the startup, Pairwise, based in Durham, North Carolina, aimed at increasing crop yield for food, fuel and fiber production.
MBX Biosciences files intention to go public
The five-year-old, clinical-stage drugmaker has already raised more than $213 million to develop therapeutics to treat rare endocrine disorders, a huge amount for a startup.
Fast-growing MBX Biosciences raises another $63.5 million in funding
MBX is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity.
Stevanato commits to paying Fishers employees a living wage
Stevanato, an Italian-based life sciences company that makes glass vials and syringes for pharmaceuticals, has committed to paying employees at its new Fishers facility no less than $70,000 annually.
Indiana’s Heartland BioWorks Hub to receive $51M in CHIPS Act funding
Indiana’s Heartland BioWorks Hub was one of 12 hubs chosen to split $500 million in implementation funding stemming from the CHIPS and Science Act.
Roche to buy bowel drugmaker Telavant for $7.1 billion
Roche has come under pressure to improve its pipeline with medicines it can commercialize soon as a windfall of revenue from products used in the COVID-19 pandemic comes to an end.
Biotech firm nearing completion of Indy radioisotopes factory
Following a $45 million renovation, RayzeBio plans to use the plant to make Actinium 225, a radioisotope used for targeted therapy for cancer.
Purple maize: Hamilton County company helps corn warn of trouble
Kyle Mohler founded Insignum Agtech with the idea of rearranging bits of corn’s DNA, then inserting them into popular field-corn hybrids.
Musk’s company aims to soon test brain implant in people
Elon Musk’s Neuralink is one of many groups working on linking brains to computers, efforts aimed at helping treat brain disorders, overcoming brain injuries and other applications.
MBX Biosciences closes on $115M in drug-development funding
The funding amount is one of the largest in recent years for an Indiana-based science startup.
Business accelerator Gener8tor announces members of latest cohort for agbioscience accelerator
This year’s cohort for Gener8tor’s gBETA agbioscience accelerator includes companies working in everything from cold storage to aquaculture. The program wraps up later this month.
Purdue project to develop treatment for deadly brain cancer wins $398,000 in federal funding
Three Indiana institutions are teaming up to try to develop a treatment for glioblastoma, a lethal cancer that begins with the brain or spinal cord, and is difficult to treat, often requiring a combination of surgery, chemotherapy and radiation.
Elanco unveils plans for new ‘epicenter of animal health innovation’
Elanco Animal Health Inc. on Tuesday broke ground and shared new designs for its planned $100 million-plus global headquarters at the former General Motors Stamping Plant site just west of downtown Indianapolis.
Scientists finally finish decoding entire human genome
Scientists said this full picture of the genome will give humanity a greater understanding of our evolution and biology while also opening the door to medical discoveries in areas like aging, neurodegenerative conditions, cancer and heart disease.
16 Tech promotes Emily Krueger to chief executive
Krueger currently serves as chief operating officer at the 16 Tech Community Corp., which oversees the 50-acre 16 Tech Innovation District on the city’s near-west side.
Cook Medical to sell reproductive health unit for $875M
The reproductive health unit includes products for obstetrics and gynecology, in vitro fertilization and assisted reproductive technology.
Initiative aims to spur innovation by connecting, analyzing data bases
Fueled with a $36 million Lilly Endowment Inc. grant, the Central Indiana Corporate Partnership has launched AnalytiXIN to promote innovations in data science throughout Indiana.